The FOCUS trial: Cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: Study protocol for a randomised controlled trial

Trials

Volumn 16, Issue 1, 2015, Pages

  Glenthøj, Louise B ^a,b   Fagerlund, Birgitte ^a,b   Randers, Lasse ^a,b   Hjorthøj, Carsten R ^a   Wenneberg, Christina ^a,b   Krakauer, Kristine ^a,b   Vosgerau, Astrid ^a,c   Gluud, Christian ^d   Medalia, Alice ^e   Roberts, David L ^f   Nordentoft, Merete ^a,b  

^a Mental Health Center Glostrup   (Denmark)

^b CINS   (Denmark)

^c Centre for Rehabilitation of Brain Injury   (Denmark)

^d University of Copenhagen   (Denmark)

^e Department of Medicine   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

At risk mental state; Cognitive remediation; Cognitive training; Neurocognitive training; Prodromal intervention; Prodromal schizophrenia; Social cognitive training; Ultra high risk for psychosis

Indexed keywords

RISPERIDONE;

ADULT; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL GLOBAL IMPRESSION SCALE; COGNITION; COGNITIVE DEFECT; COGNITIVE REMEDIATION THERAPY; COGNITIVE THERAPY; CONTROLLED STUDY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SOCIAL COGNITION; SOCIAL PSYCHOLOGY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TREATMENT OUTCOME; WECHSLER INTELLIGENCE SCALE; YOUNG MANIA RATING SCALE; ADOLESCENT; CLINICAL PROTOCOL; COMPARATIVE STUDY; PSYCHOLOGY; PSYCHOTIC DISORDERS; RISK; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; CLINICAL PROTOCOLS; COGNITION; DATA INTERPRETATION, STATISTICAL; HUMANS; PSYCHOTIC DISORDERS; RISK; SCHIZOPHRENIA;

EID: 84924232659     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-014-0542-8     Document Type: Article

References (86)

1. McGrath J, Saha S, Chant D, Welham J (2008) Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30:67-76
2. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rossler A, Schultze-Lutter F et al (2013) The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 70:107-20
3. van der Gaag M, Smit F, Bechdolf A, French P, Linszen DH, Yung AR et al (2013) Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res 149:56-62
4. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM et al (2002) Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 59:921-8
5. McGorry PD, Nelson B, Phillips LJ, Yuen HP, Francey SM, Thampi A et al (2013) Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome. J Clin Psychiatry 74:349-56
6. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW et al (2006) Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 163:790-9
7. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM et al (2010) Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 67:146-54
8. Nordentoft M, Thorup A, Petersen L, Ohlenschlaeger J, Melau M, Christensen TO et al (2006) Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr Res 83:29-40
9. Bechdolf A, Wagner M, Ruhrmann S, Harrigan S, Putzfeld V, Pukrop R et al (2012) Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry 200:22-9
10. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J et al (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 185:291-7
11. Morrison AP, French P, Stewart SL, Birchwood M, Fowler D, Gumley AI et al (2012) Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ 344:e2233
12. Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB (2011) A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res 125:54-61
13. van der Gaag M, Nieman DH, Rietdijk J, Dragt S, Ising HK, Klaassen RM et al (2012) Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial. Schizophr Bull 38:1180-8
14. Bellack AS, Gold JM, Buchanan RW (1999) Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies. Schizophr Bull 25:257-74
15. Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull 26:119-36
16. Wykes T, Spaulding WD (2011) Thinking about the future cognitive remediation therapy-what works and could we do better? Schizophr Bull 37(Suppl 2):S80-90
17. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-30
18. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT (2007) A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry 164:1791-802
19. Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L (2011) The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev 35:573-88
20. Schmidt SJ, Mueller DR, Roder V (2011) Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. Schizophr Bull 37(Suppl 2):S41-54
21. Green MF, Penn DL, Bentall R, Carpenter WT, Gaebel W, Gur RC et al (2008) Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull 34:1211-20
22. Bartholomeusz CF, Allott K (2012) Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: theoretical considerations and current state of evidence. Schizophr Res Treat 2012:815315
23. Addington J, Saeedi H, Addington D (2006) Facial affect recognition: a mediator between cognitive and social functioning in psychosis? Schizophr Res 85:142-50
24. Addington J, Saeedi H, Addington D (2006) Influence of social perception and social knowledge on cognitive and social functioning in early psychosis. Br J Psychiatry 189:373-8
25. Horton HK, Silverstein SM (2008) Social cognition as a mediator of cognition and outcome among deaf and hearing people with schizophrenia. Schizophr Res 105:125-37
26. Nienow TM, Docherty NM, Cohen AS, Dinzeo TJ (2006) Attentional dysfunction, social perception, and social competence: what is the nature of the relationship? J Abnorm Psychol 115:408-17
27. Vaskinn A, Sundet K, Friis S, Simonsen C, Birkenaes AB, Jonsdottir H et al (2008) Emotion perception and learning potential: mediators between neurocognition and social problem-solving in schizophrenia? J Int Neuropsychol Soc 14:279-88
28. Couture SM, Penn DL, Roberts DL (2006) The functional significance of social cognition in schizophrenia: a review. Schizophr Bull 32(Suppl 1):S44-63
29. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P (2011) A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry 168:472-85
30. Lewandowski KE, Eack SM, Hogarty SS, Greenwald DP, Keshavan MS (2011) Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder? Schizophr Res 125:291-4
31. Deckersbach T, Nierenberg AA, Kessler R, Lund HG, Ametrano RM, Sachs G et al (2010) RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther 16:298-307
32. Lewandowski KE, Cohen BM, Ongur D (2011) Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med 41:225-41
33. Bozikas VP, Andreou C (2011) Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature. Aust N Z J Psychiatry 45:93-108
34. Bora E, Murray RM (2014) Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull 40(4):744-55
35. Fusar-Poli P, Deste G, Smieskova R, Barlati S, Yung AR, Howes O et al (2012) Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry 69:562-71
36. Hawkins KA, Addington J, Keefe RS, Christensen B, Perkins DO, Zipurksy R et al (2004) Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr Res 67:115-22
37. Niendam TA, Bearden CE, Johnson JK, McKinley M, Loewy R, O'Brien M et al (2006) Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res 84:100-11
38. Brewer WJ, Wood SJ, Phillips LJ, Francey SM, Pantelis C, Yung AR et al (2006) Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull 32:538-55
39. Thompson AD, Bartholomeusz C, Yung AR (2011) Social cognition deficits and the 'ultra high risk' for psychosis population: a review of literature. Early Interv Psychiatry 5:192-202
40. Lin A, Wood SJ, Nelson B, Brewer WJ, Spiliotacopoulos D, Bruxner A et al (2011) Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis. Schizophr Res 132:1-7
41. Rauchensteiner S, Kawohl W, Ozgurdal S, Littmann E, Gudlowski Y, Witthaus H et al (2011) Test-performance after cognitive training in persons at risk mental state of schizophrenia and patients with schizophrenia. Psychiatry Res 185:334-9
42. Jakobsen J, Gluud C (2013) The necessity of randomized clinical trials. Br J Med Clin Res 3(3):1453-68
43. Harvey PD (2014) What is the evidence for changes in cognition and functioning over the lifespan in patients with schizophrenia? J Clin Psychiatry 75(Suppl 2):34-8
44. McGlashan TH, Johannessen JO (1996) Early detection and intervention with schizophrenia: rationale. Schizophr Bull 22:201-22
45. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M et al (2005) Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 39:964-71
46. Medalia A, Revheim N, Herlands T (2009) Cognitive remediation for psychological disorders: therapist guide. Oxford University Press, New York: Oxford
47. Medalia A, Freilich B (2008) The neuropsychological education approach to cognitive remediation (NEAR) model: practice principles and outcome studies. Am J Psychiatr Rehabil 11:2
48. Roberts DL, Penn DL, Combs DR. Social Cognition and Interaction Training SCIT: Treatment Manual. New York: Oxford University Press; In press
49. Ventura J, Liberman RP, Green MF, Shaner A, Mintz J (1998) Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res 79:163-73
50. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS (1997) Structured clinical interview for DSM-IV axis II personality disorders: SCID-II. American Psychiatric Press, Washington, DC
51. Strauss E, Sherman EMS, Spreen O, Spreen O (2006) A Compendium Of Neuropsychological Tests: Administration, Norms, And Commentary, 3rd edn. Oxford University Press, New York
52. Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L (2004) The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 68:283-97
53. Gioia GA, Kenworthy L, Isquith PK (2010) Executive function in the real world: BRIEF lessons from Mark Ylvisaker. J Head Trauma Rehabil 25:433-9
54. Keefe RS, Poe M, Walker TM, Kang JW, Harvey PD (2006) The schizophrenia cognition rating scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry 163:426-32
55. Keefe RS, Harvey PD, Goldberg TE, Gold JM, Walker TM, Kennel C et al (2008) Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). Schizophr Res 102:108-15
56. Levaux MN, Potvin S, Sepehry AA, Sablier J, Mendrek A, Stip E (2007) Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. Eur Psychiatry 22:104-15
57. Lowe C, Rabbitt P (1998) Test/re-test reliability of the CANTAB and ISPOCD neuropsychological batteries: theoretical and practical issues. Cambridge Neuropsychological Test Automated Battery. International Study of Post-Operative Cognitive Dysfunction. Neuropsychologia 36:915-23
58. Barnett JH, Robbins TW, Leeson VC, Sahakiana BJ, Joyce EM, Blackwell AD (2010) Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev 34:1161-77
59. McDonald S, Flanagan S, Rollins J, Kinch J (2003) TASIT: a new clinical tool for assessing social perception after traumatic brain injury. J Head Trauma Rehabil 18:219-38
60. Gibson CM, Penn DL, Prinstein MJ, Perkins DO, Belger A (2010) Social skill and social cognition in adolescents at genetic risk for psychosis. Schizophr Res 122:179-84
61. Kanie A, Hagiya K, Ashida S, Pu S, Kaneko K, Mogami T, Oshima S, Motoya M, Niwa SI, Inagaki A et al (2014) A new instrument for measuring multiple domains of social cognition: Construct validity of the Social Cognition Screening Questionnaire (Japanese version). Psychiatry Clin Neurosci 68(9):701-11
62. Bolte S, Poustka F, Constantino JN (2008) Assessing autistic traits: cross-cultural validation of the social responsiveness scale (SRS). Autism Res 1:354-63
63. Ventura J, Nuechterlein KH, Subotnik KL, Gutkind D, Gilbert EA (2000) Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Res 97:129-35
64. Andreasen NC (1984) Scale for the assessment of negative symptoms: SANS. Dept. of Psychiatry, College of Medicine, the University of Iowa, Iowa City, Iowa
65. Andreasen NC, Flaum M, Swayze VW 2nd, Tyrrell G, Arndt S (1990) Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry 47:615-21
66. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-9
67. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-35
68. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology - Revised (DHEW Publ No ADM 76-338). In: Rockville, MD, US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs., pp 218-22
69. Schultze-Lutter F, Ruhrmann S, Fusar-Poli P, Bechdolf A, Schimmelmann BG, Klosterkotter J (2012) Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des 18:351-7
70. Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R (2000) Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 101:323-9
71. Hilsenroth MJ, Ackerman SJ, Blagys MD, Baumann BD, Baity MR, Smith SR (2000) Reliability and Validity of DSM-IV Axis V. Am J Psychiatr 157:1858-63
72. Cornblatt BA, Auther AM, Niendam T, Smith CW, Zinberg J, Bearden CE et al (2007) Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull 33:688-702
73. Cannon-Spoor HE, Potkin SG, Wyatt RJ (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8:470-84
74. World Health Organisation ASSIST Working Group (2002) The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction 97:1183-1194
75. Heinrichs DW, Hanlon TE, Carpenter WTJR (1984) The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 10:388-98
76. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD (1979) Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann 2:197-207
77. Klingberg S, Herrlich J, Wiedemann G, Wolwer W, Meisner C, Engel C et al (2012) Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. J Nerv Ment Dis 200:569-76
78. Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ et al (2005) Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry 162:71-8
79. Becker HE, Nieman DH, Wiltink S, Dingemans PM, van de Fliert JR, Velthorst E et al (2010) Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration? Psychol Med 40:1599-606
80. Frommann I, Pukrop R, Brinkmeyer J, Bechdolf A, Ruhrmann S, Berning J et al (2011) Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early-and additional memory dysfunction in the late-prodromal state. Schizophr Bull 37:861-73
81. Eastvold AD, Heaton RK, Cadenhead KS (2007) Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophr Res 93:266-77
82. Nasrallah H, Morosini P, Gagnon DD (2008) Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia. Psychiatry Res 161:213-24
83. Ballerini A, Boccalon R, Boncompagni G, Casacchia M, Margari F, Minervini L et al (2007) An observational study in psychiatric acute patients admitted to General Hospital Psychiatric Wards in Italy. Ann Gen Psychiatry 6:2
84. Lepping P, Sambhi RS, Whittington R, Lane S, Poole R (2011) Clinical relevance of findings in trials of antipsychotics: systematic review. Br J Psychiatry 198:341-5
85. Savovic J, Jones HE, Altman DG, Harris RJ, Juni P, Pildal J et al (2012) Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 157:429-38
86. Eack SM, Greenwald DP, Hogarty SS, Cooley SJ, DiBarry AL, Montrose DM et al (2009) Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv 60:1468-76